Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

4 must-haves for health execs deploying ambient AI scribes at scale
Successfully adopting the technology across wide and varying care settings depends on a whole lot more than just technical sophistication.
Aggressively treating blood pressure, cholesterol levels fails to improve cognitive function
Targeting key cardiovascular risk factors for two full years was not linked to a reduced risk of cognitive decline or dementia.
FTC homes in on healthcare
The federal regulatory agency that exists to protect consumers and promote competition across the economy is newly focused on patients and clinicians as well as taxpayers.
Cardiovascular Business announces its Forty Under 40 Class of 2026
The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40.
FDA-approved surgical aortic valve implanted for first time in US
The next-generation valve from Corcym features a sutureless frame as well as laser-cut leaflets and thread holes.

Industry Watcher’s Digest

IT departments are budgeting more for AI in 2025 than for any other single area of investment.

artificial intelligence AI in healthcare

Stanford HAI lookback: Best-read blog posts of 2024

The year 2023 saw a shift toward open-source AI models, surging investments in generative AI and increasing AI regulation.

IV hospital room intravenous drip solution

Industry Watcher’s Digest

The FDA has finalized its recommendations for getting AI-equipped medical devices approved.

Providers, payers share actionable experiences involving healthcare AI

A large venture capital firm focused on supporting early-stage healthtech companies has a tip for AI startups targeting the healthcare sector.

Robotic aortic valve replacement (RAVR) is a new minimally invasive treatment option for symptomatic severe aortic stenosis (AS) that uses advanced robotic surgical systems. It has already started gaining momentum as an alternative to both surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).

Q&A: Pioneer heart surgeon on the development and long-term potential of robotic aortic valve replacement

It's early for RAVR, but the minimally invasive technique has already started gaining momentum as an alternative to both SAVR and TAVR. We spoke to Vinay Badhwar, MD, one of the world’s leading voices in robotic heart surgery, to learn more.

Heart surgeons with the WVU Heart and Vascular Institute have made a bit of history, performing the world’s first combined robotic aortic valve replacement (AVR) and coronary artery bypass grafting (CABG) procedure—all through one small incision. Patients requiring these procedures typically undergo open-heart surgery.

Heart surgeons perform world’s first combined robotic AVR and CABG

The entire robotic procedure was performed through one small incision. Surgeons originally recommended the 73-year-old patient undergo open-heart surgery, but she requested a less invasive alternative.

Off-label TAVR for native aortic regurgitation linked to worse outcomes

Targeting aortic regurgitation with TAVR valves built to treat aortic stenosis may be the only option a cardiologist has—but valves designed specifically to treat AR are linked to much better outcomes, according to a new meta-analysis. Edwards Lifesciences recently acquired the two companies at the center of this study, JenaValve and JC Medical.

Industry Watcher’s Digest

Federal AI guardrails are taking shape.

Care Delivery

4 must-haves for health execs deploying ambient AI scribes at scale

Aggressively treating blood pressure, cholesterol levels fails to improve cognitive function

FTC homes in on healthcare

Cardiovascular Business announces its Forty Under 40 Class of 2026

FDA-approved surgical aortic valve implanted for first time in US